Choice Architecture Based TB Preventive Therapy Prescribing
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   KNCV Tuberculosis Foundation;   Clinton Health Access Initiative, Zimbabwe;   Aurum Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Prevent TB: Choice Architecture for TPT Delivery
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   University of Witwatersrand, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Choice Architecture Based TB Preventive Therapy Prescribing
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   KNCV Tuberculosis Foundation;   Clinton Health Access Initiative, Zimbabwe;   Aurum Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Prevent TB: Choice Architecture for TPT Delivery
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   University of Witwatersrand, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Choice Architecture Based TB Preventive Therapy Prescribing
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   KNCV Tuberculosis Foundation;   Clinton Health Access Initiative, Zimbabwe;   Aurum Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Prevent TB: Choice Architecture for TPT Delivery
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   University of Witwatersrand, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Choice Architecture Based TB Preventive Therapy Prescribing
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   KNCV Tuberculosis Foundation;   Clinton Health Access Initiative, Zimbabwe;   Aurum Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Prevent TB: Choice Architecture for TPT Delivery
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   University of Witwatersrand, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Choice Architecture Based TB Preventive Therapy Prescribing
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   KNCV Tuberculosis Foundation;   Clinton Health Access Initiative, Zimbabwe;   Aurum Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Prevent TB: Choice Architecture for TPT Delivery
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   University of Witwatersrand, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Choice Architecture Based TB Preventive Therapy Prescribing
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   KNCV Tuberculosis Foundation;   Clinton Health Access Initiative, Zimbabwe;   Aurum Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Prevent TB: Choice Architecture for TPT Delivery
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   University of Witwatersrand, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Choice Architecture Based TB Preventive Therapy Prescribing
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   KNCV Tuberculosis Foundation;   Clinton Health Access Initiative, Zimbabwe;   Aurum Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Prevent TB: Choice Architecture for TPT Delivery
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   University of Witwatersrand, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Choice Architecture Based TB Preventive Therapy Prescribing
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   KNCV Tuberculosis Foundation;   Clinton Health Access Initiative, Zimbabwe;   Aurum Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Prevent TB: Choice Architecture for TPT Delivery
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   University of Witwatersrand, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Choice Architecture Based TB Preventive Therapy Prescribing
Conditions:   HIV/AIDS;   Tuberculosis Intervention:   Behavioral: Choice Architecture Sponsors:   Johns Hopkins University;   KNCV Tuberculosis Foundation;   Clinton Health Access Initiative, Zimbabwe;   Aurum Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials

Rifampin and the Contraceptive Implant
Conditions:   Contraception;   Tuberculosis Intervention:   Drug: Rifampin 600 MG Sponsors:   University of Colorado, Denver;   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2020 Category: Research Source Type: clinical trials

The curative effects of shortwave diathermy on treating Novel coronavirus (COVID-19) pneumonia: A structured summary of a study protocol for a randomised controlled trial
This study will be conducted in Tongji Hospital, Caidian, Wuhan, People ’s Republic of China.Intervention and comparatorThe experimental group will be given the nationally recommended standard medical treatment + ultra-short-wave diathermy treatment. Ultra-short-wave therapy treatment will be performed through application of ultra-short-wave therapy machine electrodes on the anterior and posterior parts of the trunk for 10 minutes, twice a day for 12 consecutive days. The comparator will be the control, not receiving ultra-short-wave therapy, and will be given only the nationally recommended standard medical treatmen...
Source: Trials - July 2, 2020 Category: Research Source Type: clinical trials

Immunization With BCG Vaccine to Prevent Tuberculosis Infection
Condition:   Tuberculosis Infection Interventions:   Biological: BCG (Tokyo 172) vaccine;   Drug: Placebo Sponsors:   Henry M. Jackson Foundation for the Advancement of Military Medicine;   United States Department of Defense;   Uniformed Services University of the Health Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2020 Category: Research Source Type: clinical trials

The Effect of Latent Tuberculosis Infection on the Pregnancy Outcome of IVF-ET
Conditions:   Infertility;   Tuberculosis Intervention:   Other: No intervention Sponsor:   Peking University Third Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2020 Category: Research Source Type: clinical trials